Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1977-9-17
|
pubmed:abstractText |
This investigation was undertaken to determine whether either d-primaquine or l-primaquine has sufficient advantage over primaquine to warrant evaluation for curative activity in human volunteers infected with Plasmodium vivax. It was found: (i) that the capacities of the isomers and the racemate to cure infections with Plasmodium cynomolgi in rhesus monkeys were essentially identical; (ii) that the subacute toxicities of the isomers and racemate for this monkey were qualitatively the same, but that l-primaquine was three to five times as toxic as d-primaquine and at least twice as toxic as primaquine; and (iii) that the acute single-dose toxicities of the isomers for mice were not only qualitatively different, but that the d isomer was at least four times as toxic as l-primaquine. Since previous appraisals of curative activity and tolerability of 8-aminoquinolines in rhesus monkeys have correlated well with appraisals in human volunteers, attention was focused on results acquired with these test subjects. The relevant evaluations showed that d-primaquine had a therapeutic index at least twice that of primaquine. If this advantage carries over to man, problems that now complicate routine use of primaquine might be obviated. Therefore, a critical comparison of d-primaquine and primaquine in human volunteers seems indicated.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-13104803,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-13104806,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-13793053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-14044759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-14361898,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-14804087,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-14945978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-16695632,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-326072,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-405875,
http://linkedlifedata.com/resource/pubmed/commentcorrection/407841-5795444
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-60
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:407841-Animals,
pubmed-meshheading:407841-Female,
pubmed-meshheading:407841-Haplorhini,
pubmed-meshheading:407841-Lethal Dose 50,
pubmed-meshheading:407841-Macaca mulatta,
pubmed-meshheading:407841-Malaria,
pubmed-meshheading:407841-Male,
pubmed-meshheading:407841-Mice,
pubmed-meshheading:407841-Primaquine,
pubmed-meshheading:407841-Stereoisomerism,
pubmed-meshheading:407841-Time Factors
|
pubmed:year |
1977
|
pubmed:articleTitle |
Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, Non-P.H.S.
|